Open Innovation
Flexible business models to fit potential partner companies

Y-Biologics develops new drugs through optimized partnerships
by having open business models based on two platform technologies (Ymax®-ABL & ALiCE).

Our strategy is to conduct joint development and investment through strategic alliances and
provide various collaboration opportunities such as CRO, joint ventures for global partnering.

Business Models

  • Licensing
  • Co-development
  • Joint-Venture
  • Research Collaboration